Mark R. Hanudel

1.1k total citations
34 papers, 435 citations indexed

About

Mark R. Hanudel is a scholar working on Nephrology, Hematology and Genetics. According to data from OpenAlex, Mark R. Hanudel has authored 34 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 10 papers in Hematology and 9 papers in Genetics. Recurrent topics in Mark R. Hanudel's work include Parathyroid Disorders and Treatments (17 papers), Iron Metabolism and Disorders (10 papers) and Hemoglobinopathies and Related Disorders (8 papers). Mark R. Hanudel is often cited by papers focused on Parathyroid Disorders and Treatments (17 papers), Iron Metabolism and Disorders (10 papers) and Hemoglobinopathies and Related Disorders (8 papers). Mark R. Hanudel collaborates with scholars based in United States, Japan and Netherlands. Mark R. Hanudel's co-authors include Isidro B. Salusky, Barbara Gales, Tomas Ganz, Victoria Gabayan, Elizabeta Nemeth, Kristine J. Chua, Joshua J. Zaritsky, Grace Jung, Marciana Laster and 博人 高橋 and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Mark R. Hanudel

29 papers receiving 428 citations

Peers

Mark R. Hanudel
Eujin Park South Korea
Sven‐Jean Tan Australia
Bora Gülhan Türkiye
Rabya Sayed United Kingdom
R H Falk United Kingdom
Mark R. Hanudel
Citations per year, relative to Mark R. Hanudel Mark R. Hanudel (= 1×) peers Marisa Santostefano

Countries citing papers authored by Mark R. Hanudel

Since Specialization
Citations

This map shows the geographic impact of Mark R. Hanudel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Hanudel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Hanudel more than expected).

Fields of papers citing papers by Mark R. Hanudel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Hanudel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Hanudel. The network helps show where Mark R. Hanudel may publish in the future.

Co-authorship network of co-authors of Mark R. Hanudel

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Hanudel. A scholar is included among the top collaborators of Mark R. Hanudel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Hanudel. Mark R. Hanudel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Czaya, Brian, Christian Castro, Grace Jung, et al.. (2025). Transgenic augmentation of erythroferrone in mice ameliorates anemia in adenine-induced chronic kidney disease. JCI Insight. 10(20). 1 indexed citations
2.
Su, L. Joseph, Yusheng Li, Bo Tao, et al.. (2025). Collagen V regulates renal function after kidney injury and can be pharmacologically targeted to enhance kidney repair in mice. Science Translational Medicine. 17(793). eads7714–eads7714.
3.
Sangkhae, Veena, Shilpa Sharma, Tomas Ganz, et al.. (2025). Disease-modifying effects of iron deficiency in mouse models of chronic renal failure. PubMed. 1(1). 100004–100004.
4.
Sharma, Shilpa, Renata C. Pereira, Elizabeta Nemeth, et al.. (2024). Utility of Blood Biomarkers to Predict Marrow Iron Stores in Children. Clinical Journal of the American Society of Nephrology. 19(7). 860–868.
5.
Tang, Jack Pengfei, et al.. (2024). Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis. Cancer Research Communications. 4(10). 2589–2597. 2 indexed citations
6.
Hanudel, Mark R., et al.. (2024). Sickle Cell Disease Related Vasculopathies and Early Evaluation in a Pediatric Population. In Vivo. 38(3). 1203–1212.
7.
Yehya, Nadir, Matt S. Zinter, Jill Thompson, et al.. (2023). Identification of molecular subphenotypes in two cohorts of paediatric ARDS. Thorax. 79(2). 128–134. 11 indexed citations
8.
Kremer, Daan, Ilja M. Nolte, Henri G. D. Leuvenink, et al.. (2023). Iron Deficiency and Nephrotoxic Heavy Metals: A Dangerous Interplay?. International Journal of Molecular Sciences. 24(6). 5315–5315. 14 indexed citations
9.
Thomas, Elizabeth T, Marciana Laster, Susan L. Furth, et al.. (2023). Associations between anemia and FGF23 in the CKiD study. Pediatric Nephrology. 39(3). 837–847. 2 indexed citations
10.
Wesseling‐Perry, Katherine, Barbara Gales, Daniela Markovic, et al.. (2022). Effects of Primary Kidney Disease Etiology on Renal Osteodystrophy in Pediatric Dialysis Patients. JBMR Plus. 6(4). e10601–e10601. 1 indexed citations
11.
Sharma, Shilpa, Nisha R. Patel, Mark R. Hanudel, et al.. (2022). Plasma FGF23 is associated with left atrial remodeling in children on hemodialysis. Pediatric Nephrology. 38(7). 2179–2187.
12.
Hanudel, Mark R., Brian Czaya, Grace Jung, et al.. (2022). Renoprotective effects of ferric citrate in a mouse model of chronic kidney disease. Scientific Reports. 12(1). 6695–6695. 4 indexed citations
13.
Hanudel, Mark R., Grace Jung, 博人 高橋, et al.. (2021). Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone. Kidney International. 100(1). 79–89. 25 indexed citations
14.
Hanudel, Mark R., Brian Czaya, Kristine J. Chua, et al.. (2021). Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin. Kidney International. 101(4). 711–719. 10 indexed citations
15.
Ray, Aniruddha, Mark R. Hanudel, Hyou‐Arm Joung, et al.. (2020). Measurement of serum phosphate levels using a mobile sensor. The Analyst. 145(5). 1841–1848. 22 indexed citations
16.
Sharma, Shilpa, Mark R. Hanudel, Joachim H. Ix, et al.. (2019). Elevated Fibroblast Growth Factor 23 Levels Are Associated With Greater Diastolic Dysfunction in ESRD. Kidney International Reports. 4(12). 1748–1751. 5 indexed citations
17.
Hanudel, Mark R., Marciana Laster, & Isidro B. Salusky. (2018). Non-renal-Related Mechanisms of FGF23 Pathophysiology. Current Osteoporosis Reports. 16(6). 724–729. 18 indexed citations
18.
Hanudel, Mark R., et al.. (2017). Fractures and Osteomalacia in a Patient Treated With Frequent Home Hemodialysis. American Journal of Kidney Diseases. 70(3). 445–448. 11 indexed citations
19.
Hanudel, Mark R. & Isidro B. Salusky. (2017). Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder. Current Osteoporosis Reports. 15(3). 198–206. 20 indexed citations
20.
Hanudel, Mark R., Katherine Wesseling‐Perry, Barbara Gales, et al.. (2015). Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients. Pediatric Nephrology. 31(4). 661–669. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026